EU honors GAPVAC project as success story

The European Union rates the GAPVAC project and Consortium as one of the recent EU research success stories! The online article highlights the results of the GAPVAC-101 phase 1 study that were recently published in Nature. Furthermore, the project is recognized as a blueprint for future personalized cancer treatments.

See the full article here.